Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2001 07:30 ET | Source: Press Release Network

Molecular Diagnostics Submits 510(K) Application to the FDA for InPath e2 Collector

CHICAGO, Oct. 1, 2001 (PRIMEZONE) -- Molecular Diagnostics, Inc., formerly Ampersand Medical (OTCBB:MCDG), announced today that it has submitted a 510(k) application to the United States Food and...
October 01, 2001 03:18 ET | Source: CeNeS Pharmaceuticals Plc

CeNeS Reports 2001 Interim Results and Planned Restructuring

CAMBRIDGE, UK, Oct. 1, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its unaudited interim financial results for the six months ended June 30, 2001 and a planned...
September 24, 2001 09:02 ET | Source: SurgiCare, Inc.

SurgiCare to Develop a Second Specialty Facility in Houston

HOUSTON, Sept. 24, 2001 (PRIMEZONE) -- SurgiCare, Inc. (AMEX:SRG), a Houston-based Ambulatory Surgical Center (ASC) provider, announced today that it has signed a Letter of Intent to develop and...
September 21, 2001 09:01 ET | Source: SurgiCare, Inc.

Taglich Brothers Upgrades SurgiCare, Inc. to a Speculative Buy

NEW YORK, Sept. 21, 2001 (PRIMEZONE) -- Taglich Brothers has upgraded SurgiCare (AMEX:SRG) to a Speculative Buy from a Not Rated, with a fifteen-month price target of $7.50. SurgiCare has...
September 20, 2001 04:31 ET | Source: Hugin Online

Acambis: Successful Phase II Challenge Trial of ChimeriVax-JE Vaccine

CAMBRIDGE, UK, Sept. 20, 2001 (PRIMEZONE) -- Acambis plc ("Acambis"), (LSE:ACM) (Nasdaq:ACAM), announces that it has successfully completed a Phase II challenge trial of its ChimeriVax-JE vaccine...
September 20, 2001 03:58 ET | Source: Hugin Online

Acambis: Interim Results for the Six Months Ended June 30, 2001

CAMBRIDGE, UK, Sept. 20, 2001 (PRIMEZONE) -- Acambis plc ("Acambis") (LSE:ACM) (Nasdaq:ACAM), announces its interim results for the six months ended June 30, 2001. Highlights: Significant...
September 20, 2001 02:26 ET | Source: Hugin Online

Acambis Identifies West Nile Vaccine Candidate

CAMBRIDGE, UK, Sept. 19, 2001 (PRIMEZONE) -- Acambis plc ("Acambis") (LSE:ACM) (Nasdaq:ACAM), announces that it has selected a vaccine candidate for the prevention of West Nile encephalitis in...
September 17, 2001 02:29 ET | Source: CeNeS Pharmaceuticals Plc

CeNeS Announces Strategic Alliance with Cardinal Health Subsidiary, IPC (International Processing Corp.) (with link)

CAMBRIDGE, UK, Sept. 16, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals Plc (LSE:CEN) today announced that it's drug delivery division, based in Scotland, has signed a strategic alliance with...
September 10, 2001 03:23 ET | Source: CeNeS Pharmaceuticals Plc

Cambridge Cognition, a Division of CeNeS Pharmaceuticals, Plans AIM Listing

CAMBRIDGE, Netherlands, Sept. 10, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced plans to float its cognition subsidiary, Cambridge Cognition, on AIM later in the...
September 10, 2001 01:58 ET | Source: Hugin Online

atugen AG Signs Technology Evaluation Agreement with Arena Pharmaceuticals

BERLIN, Germany, Sept. 10, 2001 (PRIMEZONE) -- atugen AG (GER:ATUG), a Berlin-based functional genomics company, and one of the leaders in the field of therapeutic gene discovery and validation,...